

Aminoglycoside antibiotic for topical use in otorhinolaryngology. Bactericidal effect.
Active against gram-positive and gram-negative bacteria that cause the development of infectious processes in the upper respiratory tract.
As part of combination therapy in infectious and inflammatory diseases of the upper respiratory tract, including:
Prevention and treatment of inflammatory processes after surgery.
1 ml of nasal spray solution contains:
Active substance: framycetin sulfate - 12.5 mg (8 thousand IU);
Excipients: methyl parahydroxybenzoate, sodium chloride, citric acid, distilled water.
No customer reviews for the moment.
Adults: one spray in each nostril 4-6 times a day.
Children: one spray into each nostril 3 times a day.
The average duration of therapy is 7 days. When using the bottle should be kept upright.
Allergic reactions: in isolated cases - skin manifestations.
Hypersensitivity to framycetin and other aminoglycoside antibiotics.
No clinically significant drug interactions with other drugs have been identified.
Adequate and strictly controlled clinical studies of the safety of the drug Isofra during pregnancy and lactation (breastfeeding) was not conducted.
If within 7 days of treatment the therapeutic effect is absent or weakly expressed, the drug should be withdrawn.
Due to the low degree of absorption into the systemic circulation, overdose is unlikely.
Studies and clinical trials of Framycetin (Click to expand)